Home  >  News
Eppen_SpinPro_Apr26
you can get e-magazine links on WhatsApp. Click here
News
  GlycoNex receives Japan’s PMDA approval to initiate first-in-human phase 1 trial of GNX1021 in gastrointestinal cancers,   April 16, 2026
  Debiopharm to present pre-clinical and clinical research advances in DDR inhibition, dual payload ADCs & AI-driven biomarkers at AACR 2026,   April 16, 2026
  Samsung Bioepis initiates phase 1 trial for SBE303, nectin-4 targeting antibody-drug conjugate candidate,   April 16, 2026
  US FDA reminds more than 2,200 sponsors and researchers to disclose trial results,   April 15, 2026
  Eclipse Life Sciences begins phase 2 study for novel ophthalmology steroid implant for diabetic macular edema,   April 14, 2026
  Enanta Pharma begins dosing in phase 1 trial of EDP-978, an oral, once-daily KIT inhibitor, in development to treat urticaria,   April 14, 2026
  GSK presents positive data for B7-H4-targeted ADC in gynaecological cancers,   April 14, 2026
  Kainova begins patient dosing in European expansion of its DOMISOL phase I/II trial of DT-7012, a Treg-depleting anti-CCR8 antibody in patients with advanced solid tumours,   April 13, 2026
  MetaVia begins patient dosing in Part 3 of phase 1 study of DA-1726, a GLP-1 and glucagon dual agonist to treat obesity,   April 13, 2026
  Alexion to deliver 20 presentations across gMG, NF1 plexiform neurofibromas and neuromyelitis optica spectrum disorder at AAN meeting,   April 11, 2026
  Sparian Biosciences begins phase 1 clinical trial of SBS-147; a next generation arylepoxamide receptor agonist to treat pain,   April 11, 2026
  Boehringer Ingelheim to evaluate combination of DLL3-targeting T-cell engager plus PD-L1/VEGF-A bispecific antibody in small cell lung cancer,   April 11, 2026
  Avacta doses first patient in phase Ia FOCUS clinical trial of AVA6103, a second-generation pre|CISION-enabled peptide-drug conjugate,   April 10, 2026
  NIH-supported trial shows low-cost care model reduces blood pressure in high-risk populations,   April 10, 2026
  Vanda Pharma begins Thetis study, a clinical trial of Nereus for prevention of vomiting induced by GLP-1 receptor agonists,   April 10, 2026
  Interim data from two ongoing investigator-initiated trials highlight the role of Sculptra and Restylane in addressing aesthetic changes associated with weight loss medications and menopause,   April 10, 2026
  ModeX Therapeutics initiates patient dosing in phase 1 trial of MDX2301 for the prevention of Covid-19,   April 09, 2026
  TARTAN-HF trial reveals simple heart-failure screening could help identify undiagnosed heart failure in diabetes,   April 08, 2026
  Amgen announces positive phase 3 results for subcutaneous Tepezza in adults living with moderate-to-severe active thyroid eye disease,   April 08, 2026
  Sanofi’s lunsekimig meets primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP,   April 08, 2026

  • Results Found: 16924
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 847
 Back
 
Propak_Asia_2026
HADSA_AC_Panel2026
echemi_logo26
API_China2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram